![Drug manufacturing laboratory equipment](https://www.nortonrosefulbright.com/-/media/images/nrf/thought-leadership/canada/publications/life-sciences-healthcare-lab-equipment.jpg?w=265&revision=355955d3-b814-40be-80c7-63b3ad62cb43&revision=5248910870347387904&hash=1F3BEDB56F2489EB29C4E2FCBDED3656)
Publication
Health Canada identifies lithium-ion batteries, infant bath seats, and water beads as hazards of concern
Health Canada has recently identified three new classes of products that pose a hazard of concern.
United Kingdom | Publication | January 2024
Following the recent decision of the Court of Appeal in The Pensions Ombudsman v CMG Pension Trustees Ltd & Anor, the Ombudsman stated that it was “disappointed ” that the Court had decided the Ombudsman was not a “competent court” for the purposes of concluding overpayment disputes where recoupment is sought.
On December 20, 2023, the Ombudsman reported on its website that in response to the ruling, the DWP is supporting legislative changes that would formally empower the Ombudsman to bring an outstanding overpayment dispute to an end without the need for a County Court order.
The Ombudsman has created an updated factsheet providing guidance on how overpayment disputes should be managed. In practice it is hoped that this additional step should not prove unduly burdensome, as the role of the County Court here is only to enforce the Ombudsman’s Determination, and not to reconsider the merits of the complaint.
Publication
Health Canada has recently identified three new classes of products that pose a hazard of concern.
Publication
An employer’s ability to ask for a sick note when an employee is absent from work due to illness is becoming increasingly curtailed across Canada.
Publication
Since 2022, the Government of Canada has introduced three waves of amendments to the Competition Act (Act), making substantive changes to Canada’s competition laws, with the most recent amendments receiving royal assent on June 20, 2024.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023